Beta blockers in primary hypertension: Do age and type of beta-blocker matter?
作者信息
Lindholm Lars Hjalmar, Carlberg Bo, Samuelsson Ola
机构信息
Department of Public Health and Clinical Medicine, Umeå University Hospital, Umeå, Sweden.
出版信息
J Hypertens. 2006 Nov;24(11):2143-5. doi: 10.1097/01.hjh.0000249686.65994.97.
Abstract
摘要
相似文献
1
Beta blockers in primary hypertension: Do age and type of beta-blocker matter?
J Hypertens. 2006 Nov;24(11):2143-5. doi: 10.1097/01.hjh.0000249686.65994.97.
2
[The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].[β受体阻滞剂的代谢效应。在抗高血压治疗中具有实际重要性的是什么？]
Dtsch Med Wochenschr. 1992 May 29;117(22):875-9. doi: 10.1055/s-0029-1235345.
3
beta-Blockers and hypertension: a therapeutic reappraisal.β受体阻滞剂与高血压：治疗再评估
Postgrad Med. 2005 Dec;118(6 Suppl Beta-Blockers):26-33. doi: 10.3810/pgm.12.2005.suppl43.229.
4
Practical clinical pharmacology of antihypertensive drugs.抗高血压药物的实用临床药理学
Cardiovasc Clin. 1975;7(1):143-56.
5
Treating hypertension in patients with ischaemic disease: the case for better beta-blocker usage.治疗缺血性疾病患者的高血压：更好使用β受体阻滞剂的理由。
Cardiovasc J Afr. 2008 Mar-Apr;19(2):113.
6
Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.使用肾上腺素能β受体阻滞剂和血管扩张剂进行抗高血压治疗。
Eur J Clin Pharmacol. 1972 Jun;4(3):177-81. doi: 10.1007/BF00561142.
7
The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?代谢综合征患者抗高血压治疗的选择——是时候改变推荐意见了吗？
Nephrol Dial Transplant. 2008 Nov;23(11):3389-91. doi: 10.1093/ndt/gfn455. Epub 2008 Aug 7.
8
[Beta blocker improves the endothelial function. Gas-forming blood vessel protection].[β受体阻滞剂改善内皮功能。形成气体的血管保护作用]
MMW Fortschr Med. 2003 Dec 18;145(51-52):41.
9
[Adverse side effects in the treatment of human hypertension].[人类高血压治疗中的不良副作用]
Medicina (B Aires). 1979;39 Suppl 1:100-5.
10
Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.β受体阻滞剂引起的心率降低：过于简单，无法解释β受体阻滞剂的有害作用。
J Am Coll Cardiol. 2009 Jun 2;53(22):2103-4; author reply 2106-7. doi: 10.1016/j.jacc.2008.12.074.
引用本文的文献
1
Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.在医学研究委员会（MRC）老年人试验中，65岁以上接受氢氯噻嗪加阿米洛利、阿替洛尔或安慰剂治疗的患者选定代谢参数的变化。
BMC Cardiovasc Disord. 2016 Oct 4;16(1):188. doi: 10.1186/s12872-016-0368-2.
2
Management of hypertension in the elderly.老年人高血压的管理。
Nat Rev Cardiol. 2012 Mar 13;9(5):286-96. doi: 10.1038/nrcardio.2012.27.
3
Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk.基于二氢吡啶类钙通道阻滞剂的联合疗法对心血管高危患者进行高血压的有效管理。
Int J Clin Pract. 2008 May;62(5):781-90. doi: 10.1111/j.1742-1241.2008.01713.x. Epub 2008 Mar 17.
Zotero 插件